SweetValueLab
Write for us

Solventum Corporation — Intrinsic Value & Fair Price

SOLV
NYSEHealthcareMedical - Instruments & SuppliesCIK 0001964738solventum.comAbout SOLV
Last close · Oct 16, 202685.81−2.05 (−2.33%)
Market cap$14.6B
Model value · DCF · Perpetuity growth · 5y
189.85
Solventum closed at $85.81 — undervalued by 55% vs model.
119.22the model's range443.66

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
57.28 – 206.05
Wall St. target
101.00 15% below
Below model, 1y
20 of 20 days

Price and model value

Embed this card

SOLV's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Research on SOLV

No posts on SOLV yet.
Studied SOLV from its filings? Guest posts are reviewed before they go live.Write about SOLV →

How it is valued

Valued asMature & stable
Low/slowing growth (~1% recent)Moderate margins (19% net margin)Highly cyclical earningsNegative free cash flow
What growth the price implies: the reverse DCF

Key figures

FY2025 · chosen for mature companies
P/E
9.7×
EV / EBITDA
7.4×
FCF yield
-0.1%
Dividend yield, TTM
0.00%
Beta
0.70
Cost of capital (WACC)
8.30%
On the lists: #14 Lowest P/E
Full financials

Analyst actions

third-party, quoted
08-06Mizuho Securities · target113.00
08-06UBS · target101.00
08-06Stifel Nicolaus · target100.00
07-28UBS · “Buy” from “Neutral”upgrade
Ratings, targets and estimates

Comparable companies

by business, not by industry label
1 more company lists SOLV as a comparable

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just SOLV. No account.

About Solventum

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

CEO
Bryan C. Hanson
Headquarters
Eagan, MN
Employees
20,584
IPO
2024-04-01
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.